New developments in transcatheter therapy of mitral valve disease
| Autor: | Mariuca Vasa-Nicotera, Stephan Fichtlscherer, Claudia Walther, Mani Arsalan, Thomas Walther, Tomas Holubec |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Pulmonary and Respiratory Medicine
medicine.medical_specialty Valve surgery business.industry MitraClip Disease Perioperative 030204 cardiovascular system & hematology medicine.disease Surgery 03 medical and health sciences 0302 clinical medicine medicine.anatomical_structure Mitral valve Heart failure Review Article on Interventional Cardiology Transcatheter therapy medicine 030212 general & internal medicine business Mitral valve regurgitation |
| Zdroj: | J Thorac Dis |
| Popis: | Mitral valve regurgitation (MR) belongs to one of the most common acquired valve diseases in western countries with increasing prevalence in older age. For patients with high perioperative risk and older age prohibitive for valve surgery, the development of transcatheter mitral valve therapies offers new options. Assessment of the severity and etiology of MR and thorough imaging of the mitral valve anatomy and pathology are necessary prerequisites for appropriate decision making in the field of transcatheter mitral valve therapies. Different transcatheter repair and replacement techniques are on the market, most of them mimicking surgical techniques. With some techniques (e.g., the MitraClip device), there is good clinical experience (>80,000 devices implanted worldwide), and evidence (three randomized studies), whereas for newer procedures, safety and efficacy data are still very limited. Transcatheter mitral repair and replacement techniques have to be considered as complementary treatment options for high-risk patients indicated by the Heart Teams. The different techniques and devices will be introduced and discussed in the following paper. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|